Immunotherapeutic targeting of LIGHT/LTβR/HVEM pathway fully recapitulates the reduced cytotoxic phenotype of LIGHT-deficient T cells

References

• Croft M. The role of TNF superfamily members in T-cell function and diseases. Nat Rev Immunol 2009; 9:271-85; PMID:19319144; http://dx.doi.org/10.1038/nri2526
   PubMed Web of Science ®Google Scholar
• Croft M. The TNF family in T cell differentiation and function–unanswered questions and future directions. Semin Immunol 2014; 26:183-90; PMID:24613728; http://dx.doi.org/10.1016/j.smim.2014.02.005
   PubMed Web of Science ®Google Scholar
• Sedy J, Bekiaris V, Ware CF. Tumor Necrosis Factor Superfamily in Innate Immunity and Inflammation. Cold Spring Harb Perspect Biol 2014; 7:a016279; PMID:25524549
   PubMedGoogle Scholar
• Croft M, Benedict CA, Ware CF. Clinical targeting of the TNF and TNFR superfamilies. Nat Rev Drug Discov 2013; 12:147-68; PMID:23334208; http://dx.doi.org/10.1038/nrd3930
   PubMed Web of Science ®Google Scholar
• Ware CF. Targeting lymphocyte activation through the lymphotoxin and LIGHT pathways. Immunol Rev 2008; 223:186-201; PMID:18613837; http://dx.doi.org/10.1111/j.1600-065X.2008.00629.x
   PubMed Web of Science ®Google Scholar
• Mauri DN, Ebner R, Montgomery RI, Kochel KD, Cheung TC, Yu GL, Ruben S, Murphy M, Eisenberg RJ, Cohen GH, et al. LIGHT, a new member of the TNF superfamily, and lymphotoxin α are ligands for herpesvirus entry mediator. Immunity 1998; 8:21-30; PMID:9462508; http://dx.doi.org/10.1016/S1074-7613(00)80455-0
   PubMed Web of Science ®Google Scholar
• Rooney IA, Butrovich KD, Glass AA, Borboroglu S, Benedict CA, Whitbeck JC, Cohen GH, Eisenberg RJ, Ware CF. The lymphotoxin-β receptor is necessary and sufficient for LIGHT-mediated apoptosis of tumor cells. J Biol Chem 2000; 275:14307-15; PMID:10799510; http://dx.doi.org/10.1074/jbc.275.19.14307
   PubMed Web of Science ®Google Scholar
• Zhai Y, Guo R, Hsu TL, Yu GL, Ni J, Kwon BS, Jiang GW, Lu J, Tan J, Ugustus M, et al. LIGHT, a novel ligand for lymphotoxin β receptor and TR2/HVEM induces apoptosis and suppresses in vivo tumor formation via gene transfer. J Clin Invest 1998; 102:1142-51; PMID:9739048; http://dx.doi.org/10.1172/JCI3492
   PubMed Web of Science ®Google Scholar
• Granger SW, Butrovich KD, Houshmand P, Edwards WR, Ware CF. Genomic characterization of LIGHT reveals linkage to an immune response locus on chromosome 19p13.3 and distinct isoforms generated by alternate splicing or proteolysis. J Immunol 2001; 167:5122-8; PMID:11673523; http://dx.doi.org/10.4049/jimmunol.167.9.5122
   PubMed Web of Science ®Google Scholar
• Zhang J, Salcedo TW, Wan X, Ullrich S, Hu B, Gregorio T, Feng P, Qi S, Chen H, Cho YH, et al. Modulation of T-cell responses to alloantigens by TR6/DcR3. J Clin Invest 2001; 107:1459-68; PMID:11390428; http://dx.doi.org/10.1172/JCI12159
   PubMed Web of Science ®Google Scholar
• Yu KY, Kwon B, Ni J, Zhai Y, Ebner R, Kwon BS. A newly identified member of tumor necrosis factor receptor superfamily (TR6) suppresses LIGHT-mediated apoptosis. J Biol Chem 1999; 274:13733-6; PMID:10318773; http://dx.doi.org/10.1074/jbc.274.20.13733
   PubMed Web of Science ®Google Scholar
• del Rio ML, Fernandez-Renedo C, Scheu S, Pfeffer K, Shintani Y, Kronenberg M, Chaloin O, Schneider P, Rodriguez-Barbosa JI. Therapeutic blockade of LIGHT interaction with herpesvirus entry mediator and lymphotoxin β receptor attenuates in vivo cytotoxic allogeneic responses. Transplantation 2014; 98:1165-74; PMID:25226173; http://dx.doi.org/10.1097/TP.0000000000000417
   PubMed Web of Science ®Google Scholar
• Morel Y, Schiano de Colella JM, Harrop J, Deen KC, Holmes SD, Wattam TA, Khandekar SS, Truneh A, Sweet RW, Gastaut JA, et al. Reciprocal expression of the TNF family receptor herpes virus entry mediator and its ligand LIGHT on activated T cells: LIGHT down-regulates its own receptor. J Immunol 2000; 165:4397-404; PMID:11035077; http://dx.doi.org/10.4049/jimmunol.165.8.4397
   PubMed Web of Science ®Google Scholar
• Force WR, Walter BN, Hession C, Tizard R, Kozak CA, Browning JL, Ware CF. Mouse lymphotoxin-β receptor. Molecular genetics, ligand binding, and expression. J Immunol 1995; 155:5280-8; PMID:7594541
   PubMed Web of Science ®Google Scholar
• Croft M, Duan W, Choi H, Eun SY, Madireddi S, Mehta A. TNF superfamily in inflammatory disease: translating basic insights. Trends Immunol 2012; 33:144-52; PMID:22169337; http://dx.doi.org/10.1016/j.it.2011.10.004
   PubMed Web of Science ®Google Scholar
• Fan K, Wang H, Wei H, Zhou Q, Kou G, Hou S, Qian W, Dai J, Li B, Zhang Y, et al. Blockade of LIGHT/HVEM and B7/CD28 signaling facilitates long-term islet graft survival with development of allospecific tolerance. Transplantation 2007; 84:746-54; PMID:17893608; http://dx.doi.org/10.1097/01.tp.0000280545.14489.df
   PubMed Web of Science ®Google Scholar
• Ye Q, Fraser CC, Gao W, Wang L, Busfield SJ, Wang C, Qiu Y, Coyle AJ, Gutierrez-Ramos JC, Hancock WW. Modulation of LIGHT-HVEM costimulation prolongs cardiac allograft survival. J Exp Med 2002; 195:795-800; PMID:11901205; http://dx.doi.org/10.1084/jem.20012088
   PubMed Web of Science ®Google Scholar
• Tamada K, Shimozaki K, Chapoval AI, Zhu G, Sica G, Flies D, Boone T, Hsu H, Fu YX, Nagata S, et al. Modulation of T-cell-mediated immunity in tumor and graft-vs.-host disease models through the LIGHT co-stimulatory pathway. Nat Med 2000; 6:283-9; PMID:10700230; http://dx.doi.org/10.1038/73136
   PubMed Web of Science ®Google Scholar
• Scheu S, Alferink J, Potzel T, Barchet W, Kalinke U, Pfeffer K. Targeted disruption of LIGHT causes defects in costimulatory T cell activation and reveals cooperation with lymphotoxin β in mesenteric lymph node genesis. J ExpMed 2002; 195:1613-24; http://dx.doi.org/10.1084/jem.20020215
   Web of Science ®Google Scholar
• Tamada K, Shimozaki K, Chapoval AI, Zhai Y, Su J, Chen SF, Hsieh SL, Nagata S, Ni J, Chen L. LIGHT, a TNF-like molecule, costimulates T cell proliferation and is required for dendritic cell-mediated allogeneic T cell response. J Immunol 2000; 164:4105-10; PMID:10754304; http://dx.doi.org/10.4049/jimmunol.164.8.4105
   PubMed Web of Science ®Google Scholar
• Morel Y, Truneh A, Sweet RW, Olive D, Costello RT. The TNF superfamily members LIGHT and CD154 (CD40 ligand) costimulate induction of dendritic cell maturation and elicit specific CTL activity. J Immunol 2001; 167:2479-86; PMID:11509586; http://dx.doi.org/10.4049/jimmunol.167.5.2479
   PubMed Web of Science ®Google Scholar
• Holmes TD, Wilson EB, Black EV, Benest AV, Vaz C, Tan B, Tanavde VM, Cook GP. Licensed human natural killer cells aid dendritic cell maturation via TNFSF14/LIGHT. Proc Natl Acad Sci U S A 2014; 111:E5688-96; PMID:25512551; http://dx.doi.org/10.1073/pnas.1411072112
   PubMed Web of Science ®Google Scholar
• Wan X, Zhang J, Luo H, Shi G, Kapnik E, Kim S, Kanakaraj P, Wu J. A TNF family member LIGHT transduces costimulatory signals into human T cells. J Immunol 2002; 169:6813-21; PMID:12471113; http://dx.doi.org/10.4049/jimmunol.169.12.6813
   PubMed Web of Science ®Google Scholar
• Shi G, Luo H, Wan X, Salcedo TW, Zhang J, Wu J. Mouse T cells receive costimulatory signals from LIGHT, a TNF family member. Blood 2002; 100:3279-86; PMID:12384428; http://dx.doi.org/10.1182/blood-2002-05-1404
   PubMed Web of Science ®Google Scholar
• Granger SW, Rickert S. LIGHT-HVEM signaling and the regulation of T cell-mediated immunity. Cytokine Growth Factor Rev 2003; 14:289-96; PMID:12787566; http://dx.doi.org/10.1016/S1359-6101(03)00031-5
   PubMed Web of Science ®Google Scholar
• Xu Y, Flies AS, Flies DB, Zhu G, Anand S, Flies SJ, Xu H, Anders RA, Hancock WW, Chen L, et al. Selective targeting of the LIGHT-HVEM costimulatory system for the treatment of graft-versus-host disease. Blood 2007; 109:4097-104; PMID:17179227; http://dx.doi.org/10.1182/blood-2006-09-047332
   PubMed Web of Science ®Google Scholar
• Chattopadhyay PK, Yu J, Roederer M. A live-cell assay to detect antigen-specific CD4+ T cells with diverse cytokine profiles. Nat Med 2005; 11:1113-7; PMID:16186817; http://dx.doi.org/10.1038/nm1293
   PubMed Web of Science ®Google Scholar
• Zhu M, Yang Y, Wang Y, Wang Z, Fu YX. LIGHT regulates inflamed draining lymph node hypertrophy. J Immunol 2011; 186:7156-63; PMID:21572030; http://dx.doi.org/10.4049/jimmunol.1002097
   PubMed Web of Science ®Google Scholar
• Del Rio ML, Jones ND, Buhler L, Norris P, Shintani Y, Ware CF, Rodriguez-Barbosa JI. Selective blockade of herpesvirus entry mediator-B and T lymphocyte attenuator pathway ameliorates acute graft-versus-host reaction. J Immunol 2012; 188:4885-96; PMID:22490863; http://dx.doi.org/10.4049/jimmunol.1103698
   PubMed Web of Science ®Google Scholar
• Fan Z, Yu P, Wang Y, Wang Y, Fu ML, Liu W, Sun Y, Fu YX. NK-cell activation by LIGHT triggers tumor-specific CD8+ T-cell immunity to reject established tumors. Blood 2006; 107:1342-51; PMID:16223768; http://dx.doi.org/10.1182/blood-2005-08-3485
   PubMed Web of Science ®Google Scholar
• Pulaiev RA, Puliaeva IA, Ryan AE, Via CS. The Parent-into-F1 Model of Graft-vs-Host Disease as a Model of In Vivo T Cell Function and Immunomodulation. Curr Med Chem Immunol Endocr Metab Agents 2005; 5:575-83; PMID:19865585; http://dx.doi.org/10.2174/156801305774962204
   PubMedGoogle Scholar
• Tschetter JR, Mozes E, Shearer GM. Progression from acute to chronic disease in a murine parent-into-F1 model of graft-versus-host disease. J Immunol 2000; 165:5987-94; PMID:11067962; http://dx.doi.org/10.4049/jimmunol.165.10.5987
   PubMed Web of Science ®Google Scholar
• Sarkar S, Kalia V, Haining WN, Konieczny BT, Subramaniam S, Ahmed R. Functional and genomic profiling of effector CD8 T cell subsets with distinct memory fates. J Exp Med 2008; 205:625-40; PMID:18316415; http://dx.doi.org/10.1084/jem.20071641
   PubMed Web of Science ®Google Scholar
• Kaech SM, Tan JT, Wherry EJ, Konieczny BT, Surh CD, Ahmed R. Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells. Nat Immunol 2003; 4:1191-8; PMID:14625547; http://dx.doi.org/10.1038/ni1009
   PubMed Web of Science ®Google Scholar
• Ferrer IR, Wagener ME, Song M, Ford ML. CD154 blockade alters innate immune cell recruitment and programs alloreactive CD8+ T cells into KLRG-1(high) short-lived effector T cells. PloS One 2012; 7:e40559; PMID:22792369; http://dx.doi.org/10.1371/journal.pone.0040559
   PubMedGoogle Scholar
• Ware CF. Protein therapeutics targeted at the TNF superfamily. Adv Pharmacol (San Diego, Calif) 2013; 66:51-80; http://dx.doi.org/10.1016/B978-0-12-404717-4.00002-0
   PubMedGoogle Scholar
• Page EK, Dar WA, Knechtle SJ. Biologics in organ transplantation. TransplInt 2012; 25:707-19; http://dx.doi.org/10.1111/j.1432-2277.2012.01456.x
   Web of Science ®Google Scholar
• Miller JF, Morahan G. Peripheral T cell tolerance. Annu Rev Immunol 1992; 10:51-69; PMID:1590995; http://dx.doi.org/10.1146/annurev.iy.10.040192.000411
   PubMed Web of Science ®Google Scholar
• van Parijs L, Perez VL, Abbas AK. Mechanisms of peripheral T cell tolerance. Novartis Found Symp 1998; 215:5-14; PMID:9760568; http://dx.doi.org/10.1002/9780470515525.ch2
   PubMedGoogle Scholar
• Schwartz RH. T cell anergy. Annu Rev Immunol 2003; 21:305-34; PMID:12471050; http://dx.doi.org/10.1146/annurev.immunol.21.120601.141110
   PubMed Web of Science ®Google Scholar
• Schoenberger SP, Toes RE, van der Voort EI, Offringa R, Melief CJ. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 1998; 393:480-3; PMID:9624005; http://dx.doi.org/10.1038/31002
   PubMed Web of Science ®Google Scholar
• Judge TA, Wu Z, Zheng XG, Sharpe AH, Sayegh MH, Turka LA. The role of CD80, CD86, and CTLA4 in alloimmune responses and the induction of long-term allograft survival. J Immunol 1999; 162:1947-51; PMID:9973463
   PubMed Web of Science ®Google Scholar
• Hargreaves RE, Monk NJ, Jurcevic S. Selective depletion of activated T cells: the CD40L-specific antibody experience. Trends Mol Med 2004; 10:130-5; PMID:15102356; http://dx.doi.org/10.1016/j.molmed.2004.01.009
   PubMed Web of Science ®Google Scholar
• Tran HM, Nickerson PW, Restifo AC, Ivis-Woodward MA, Patel A, Allen RD, Strom TB, O'Connell PJ. Distinct mechanisms for the induction and maintenance of allograft tolerance with CTLA4-Fc treatment. J Immunol (Baltimore, Md : 1950) 1997; 159:2232-9
   PubMed Web of Science ®Google Scholar
• Wekerle T, Grinyo JM. Belatacept: from rational design to clinical application. Transpl Int 2012; 25:139-50; PMID:22151353; http://dx.doi.org/10.1111/j.1432-2277.2011.01386.x
   PubMed Web of Science ®Google Scholar
• Ford ML, Larsen CP. Translating costimulation blockade to the clinic: lessons learned from three pathways. Immunol Rev 2009; 229:294-306; PMID:19426229; http://dx.doi.org/10.1111/j.1600-065X.2009.00776.x
   PubMed Web of Science ®Google Scholar
• Williams MA, Trambley J, Ha J, Adams AB, Durham MM, Rees P, Cowan SR, Pearson TC, Larsen CP. Genetic characterization of strain differences in the ability to mediate CD40/CD28-independent rejection of skin allografts. J Immunol 2000; 165:6849-57; PMID:11120808; http://dx.doi.org/10.4049/jimmunol.165.12.6849
   PubMed Web of Science ®Google Scholar
• Trambley J, Bingaman AW, Lin A, Elwood ET, Waitze SY, Ha J, Durham MM, Corbascio M, Cowan SR, Pearson TC, et al. Asialo GM1(+) CD8(+) T cells play a critical role in costimulation blockade-resistant allograft rejection. JClinInvest 1999; 104:1715-22; http://dx.doi.org/10.1172/JCI8082
   PubMed Web of Science ®Google Scholar
• Doherty TA, Croft M. Therapeutic potential of targeting TNF/TNFR family members in asthma. Immunotherapy 2011; 3:919-21; PMID:21843077; http://dx.doi.org/10.2217/imt.11.88
   PubMed Web of Science ®Google Scholar
• Cheung TC. Modulation of T cell proliferation through the LIGHT-HVEM-BTLA cosignaling pathway. Recent Pat DNA Gene Seq 2009; 3:177-82; PMID:19702559; http://dx.doi.org/10.2174/187221509789318342
   PubMedGoogle Scholar
• Gommerman JL, Browning JL. Effective expression and purification of bioactive recombinant soluble LIGHT. Nat Rev Immunol 2003; 3:642-55; PMID:12974479; http://dx.doi.org/10.1038/nri1151
   PubMed Web of Science ®Google Scholar
• Tsuji I, Iwamoto K, Shintani Y. Effective expression and purification of bioactive recombinant soluble LIGHT. Methods Mol Biol (Clifton, NJ) 2014; 1155:201-13; http://dx.doi.org/10.1007/978-1-4939-0669-7_17
   PubMedGoogle Scholar
• Wang J, Lo JC, Foster A, Yu P, Chen HM, Wang Y, Tamada K, Chen L, Fu YX. The regulation of T cell homeostasis and autoimmunity by T cell-derived LIGHT. J Clin Invest 2001; 108:1771-80; PMID:11748260; http://dx.doi.org/10.1172/JCI200113827
   PubMed Web of Science ®Google Scholar
• Anand S, Wang P, Yoshimura K, Choi IH, Hilliard A, Chen YH, Wang CR, Schulick R, Flies AS, Flies DB, et al. Essential role of TNF family molecule LIGHT as a cytokine in the pathogenesis of hepatitis. J Clin Invest 2006; 116:1045-51; PMID:16557300; http://dx.doi.org/10.1172/JCI27083
   PubMed Web of Science ®Google Scholar
• Fava RA, Notidis E, Hunt J, Szanya V, Ratcliffe N, Ngam-Ek A, De Fougerolles AR, Sprague A, Browning JL. A role for the lymphotoxin/LIGHT axis in the pathogenesis of murine collagen-induced arthritis. J Immunol (Baltimore, Md : 1950) 2003; 171:115-26; http://dx.doi.org/10.4049/jimmunol.171.1.115
   PubMed Web of Science ®Google Scholar
• Herro R, Da Silva Antunes R, Aguilera AR, Tamada K, Croft M. Tumor necrosis factor superfamily 14 (LIGHT) controls thymic stromal lymphopoietin to drive pulmonary fibrosis. J Allergy Clin Immunol 2015; 136(3):757-68; PMID:25680454
   PubMed Web of Science ®Google Scholar
• Doherty TA, Soroosh P, Khorram N, Fukuyama S, Rosenthal P, Cho JY, Norris PS, Choi H, Scheu S, Pfeffer K, et al. The tumor necrosis factor family member LIGHT is a target for asthmatic airway remodeling. Nat Med 2011; 17:596-603; PMID:21499267; http://dx.doi.org/10.1038/nm.2356
   PubMed Web of Science ®Google Scholar
• Herro R, Antunes Rda S, Aguilera AR, Tamada K, Croft M. The Tumor Necrosis Factor Superfamily Molecule LIGHT Promotes Keratinocyte Activity and Skin Fibrosis. J Invest Dermatol 2015; 135:2109-18; PMID:25789702; http://dx.doi.org/10.1038/jid.2015.110
   PubMed Web of Science ®Google Scholar
• Brunetti G, Rizzi R, Oranger A, Gigante I, Mori G, Taurino G, Mongelli T, Colaianni G, Di Benedetto A, Tamma R, et al. LIGHT/TNFSF14 increases osteoclastogenesis and decreases osteoblastogenesis in multiple myeloma-bone disease. Oncotarget 2014; 5:12950-67; PMID:25460501; http://dx.doi.org/10.18632/oncotarget.2633
   PubMed Web of Science ®Google Scholar
• Bruhns P. Properties of mouse and human IgG receptors and their contribution to disease models. Blood 2012; 119:5640-9; PMID:22535666; http://dx.doi.org/10.1182/blood-2012-01-380121
   PubMed Web of Science ®Google Scholar
• Bournazos S, DiLillo DJ, Ravetch JV. The role of Fc-FcgammaR interactions in IgG-mediated microbial neutralization. J Exp Med 2015; PMID:26282878; http://dx.doi.org/10.1084/jem.20151267
   PubMed Web of Science ®Google Scholar
• Nimmerjahn F, Ravetch JV. Divergent immunoglobulin g subclass activity through selective Fc receptor binding. Science (New York, NY) 2005; 310:1510-2; http://dx.doi.org/10.1126/science.1118948
   PubMed Web of Science ®Google Scholar
• Biburger M, Lux A, Nimmerjahn F. How immunoglobulin G antibodies kill target cells: revisiting an old paradigm. Adv Immunol 2014; 124:67-94; PMID:25175773; http://dx.doi.org/10.1016/B978-0-12-800147-9.00003-0
   PubMed Web of Science ®Google Scholar
• Cudkowicz G, Bennett M. Peculiar immunobiology of bone marrow allografts. II. Rejection of parental grafts by resistant F 1 hybrid mice. J Exp Med 1971; 134:1513-28; PMID:4942407; http://dx.doi.org/10.1084/jem.134.6.1513
   PubMed Web of Science ®Google Scholar
• Soloviova K, Puliaiev M, Foster A, Via CS. The parent-into-F1 murine model in the study of lupus-like autoimmunity and CD8 cytotoxic T lymphocyte function. Methods Mol Biol (Clifton, NJ) 2012; 900:253-70; http://dx.doi.org/10.1007/978-1-60761-720-4_12
   PubMedGoogle Scholar
• Summers-DeLuca LE, McCarthy DD, Cosovic B, Ward LA, Lo CC, Scheu S, Pfeffer K, Gommerman JL. Expression of lymphotoxin-alphabeta on antigen-specific T cells is required for DC function. J Exp Med 2007; 204:1071-81; PMID:17452522; http://dx.doi.org/10.1084/jem.20061968
   PubMed Web of Science ®Google Scholar
• Gommerman JL, Summers dL. LTbetaR and CD40: working together in dendritic cells to optimize immune responses. Immunol Rev 2011; 244:85-98; PMID:22017433; http://dx.doi.org/10.1111/j.1600-065X.2011.01056.x
   PubMed Web of Science ®Google Scholar
• Del Rio ML, Schneider P, Fernandez-Renedo C, Perez-Simon JA, Rodriguez-Barbosa JI. LIGHT/HVEM/LTbetaR Interaction as a Target for the Modulation of the Allogeneic Immune Response in Transplantation. Am J Transplant 2013; 13:541-51; PMID:23356438; http://dx.doi.org/10.1111/ajt.12089
   PubMed Web of Science ®Google Scholar
• Schenk AD, Gorbacheva V, Rabant M, Fairchild RL, Valujskikh A. Effector functions of donor-reactive CD8 memory T cells are dependent on ICOS induced during division in cardiac grafts. Am J Transplantation 2009; 9:64-73; http://dx.doi.org/10.1111/j.1600-6143.2008.02460.x
   PubMed Web of Science ®Google Scholar
• Rodriguez-Barbosa JI, Gutierrez Martin CB, Tascon RI, Suarez J, Rodriguez Ferri EF. Evidence obtained with monoclonal antibodies that O antigen is the major antigen responsible for the cross-reactivities between serotypes 4 and 7 of Actinobacillus (Haemophilus) pleuropneumoniae. Clin Diagn Lab Immunol 1995; 2:563-8; PMID:8548535
   PubMedGoogle Scholar
• Ito T, Iwamoto K, Tsuji I, Tsubouchi H, Omae H, Sato T, Ohba H, Kurokawa T, Taniyama Y, Shintani Y. Trimerization of murine TNF ligand family member LIGHT increases the cytotoxic activity against the FM3A mammary carcinoma cell line. Appl Microbiol Biotechnol 2011; 90:1691-9; PMID:21400099; http://dx.doi.org/10.1007/s00253-011-3168-8
   PubMed Web of Science ®Google Scholar
• Schneider P, Willen L, Smulski CR. Tools and techniques to study ligand-receptor interactions and receptor activation by TNF superfamily members. Meth Enzymol 2014; 545:103-25; PMID:25065888; http://dx.doi.org/10.1016/B978-0-12-801430-1.00005-6
   PubMed Web of Science ®Google Scholar
• Nguyen HH, Park J, Kang S, Kim M. Surface plasmon resonance: a versatile technique for biosensor applications. Sensors (Basel, Switzerland) 2015; 15:10481-510; PMID:25951336; http://dx.doi.org/10.3390/s150510481
   PubMed Web of Science ®Google Scholar
• Del Rio ML, Kaye J, Rodriguez-Barbosa JI. Detection of protein on BTLA(low) cells and in vivo antibody-mediated down-modulation of BTLA on lymphoid and myeloid cells of C57BL/6 and BALB/c BTLA allelic variants. Immunobiology 2010; 215:570-8; http://dx.doi.org/10.1016/j.imbio.2009.09.008
   PubMed Web of Science ®Google Scholar
• Unkeless JC. Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors. J Exp Med 1979; 150:580-96; PMID:90108; http://dx.doi.org/10.1084/jem.150.3.580
   PubMed Web of Science ®Google Scholar
• Lyons AB. Analysing cell division in vivo and in vitro using flow cytometric measurement of CFSE dye dilution. J Immunol Methods 2000; 243:147-54; PMID:10986412; http://dx.doi.org/10.1016/S0022-1759(00)00231-3
   PubMed Web of Science ®Google Scholar